MCF Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

MCF Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-30	Closed	-$18.7K	–	1106
2026 Q2	$18.7K	Sell	30 -12	-29%	-$8.17K	﹤0.01%	913
2026 Q1	$32.5K	Sell	42 -3	-7%	-$2.3K	﹤0.01%	702
2025 Q4	$34.7K	Buy	45 +15	+50%	+$10.2K	﹤0.01%	575
2025 Q3	$16.9K	Hold	30	–	–	﹤0.01%	608
2025 Q2	$15.8K	Hold	30	–	–	﹤0.01%	589
2025 Q1	$19K	Sell	30 -6	-17%	-$4.13K	﹤0.01%	561
2024 Q4	$25.6K	Hold	36	–	–	﹤0.01%	509
2024 Q3	$37.8K	Sell	36 -5	-12%	-$5.56K	﹤0.01%	437
2024 Q2	$43.1K	Buy	41 +6	+17%	+$5.82K	﹤0.01%	410
2024 Q1	$33.7K	Sell	35 -1	-3%	-$951	﹤0.01%	443
2023 Q4	$31.6K	Buy	36 +12	+50%	+$9.9K	﹤0.01%	440
2023 Q3	$19.8K	Hold	24	–	–	﹤0.01%	488
2023 Q2	$17.2K	Hold	24	–	–	﹤0.01%	497
2023 Q1	$19.7K	Buy	24 +20	+500%	+$15.1K	﹤0.01%	475
2022 Q4	$2.89K	Hold	4	–	–	﹤0.01%	642
2022 Q3	$3K	Hold	4	–	–	﹤0.01%	653
2022 Q2	$2K	Hold	4	–	–	﹤0.01%	640
2022 Q1	$3K	Buy	+4	New	+$2.53K	﹤0.01%	613
2021 Q4	–	Sell	-4	Closed	-$2K	–	529
2021 Q3	$2K	Buy	+4	New	+$2.48K	﹤0.01%	630

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.22B AUM 4.07% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

MCF Advisors's REGN Position: Q3 2026 in Review

MCF Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2026, closing a stake of 30 shares — an estimated $18.7K sold.

MCF Advisors first reported a position in REGN in Q3 2021 and held it in 19 quarters. The position peaked at $43.1K in Q2 2024. 547 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

MCF Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
MCF Advisors sold 30 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $18.7K.
MCF Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2021 and held it in 19 quarters.
MCF Advisors's Regeneron Pharmaceuticals position peaked at $43.1K in Q2 2024.
547 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on MCF Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.